Virtu Financial LLC Purple Biotech Ltd. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.41 - $0.86 $1,309 - $2,747	3,195 Added 19.87%	19,273 $8,000
Q1 2024 May 20, 2024	BUY	$0.58 - $0.92 $9,325 - $14,791	16,078 New	16,078 $11,000
Q2 2022 Aug 09, 2022	BUY	$2.39 - $4.15 $32,788 - $56,933	13,719 New	13,719 $33,000
Q2 2021 Sep 17, 2021	SELL	$3.75 - $6.72 $81,217 - $145,541	-21,658 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$3.93 - $6.99 $5,226 - $9,296	-1,330 Reduced 5.79%	21,658 $89,000
Q4 2020 Feb 24, 2021	BUY	$3.81 - $4.73 $87,584 - $108,733	22,988 New	22,988 $88,000

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $67M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.